Unresectable Pancreatic Ductal Adenocarcinoma
specificA pancreatic ductal adenocarcinoma that is not amenable to surgical resection.
14
Centers
14
Active Trials
—
Cancer Funding
Top Centers for Unresectable Pancreatic Ductal Adenocarcinoma(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 53.6 |
| 2 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 53.6 |
| 3 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 53.6 |
| 4 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 53.6 |
| 5 | NCI Comprehensive Active Research Program | 53.6 |
| 6 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 53.6 |
| 7 | NCI Comprehensive Active Research Program | 53.6 |
| 8 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive Active Research Program | 53.6 |
| 9 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 53.6 |
| 10 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 53.6 |
| 11 | NCI Comprehensive Active Research Program | 53.6 |
| 12 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.6 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.6 |
| 14 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 53.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →